Medical News

RSS

Wyse Technology announces partnership, continued success with LLS

Wyse Technology, the inventor and global leader in cloud client computing, today announced its partnership and continued success with The Leukemia and Lymphoma Society, the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services.

13 Jul 2010

Researchers use topological optimization to design facial bone replacements

Scientists are using the engineering technology behind the creation of high-performance aircraft components to design 3-D models for the replacement of delicate and complex facial bones lost to cancer surgery or trauma.

13 Jul 2010

Community-based interventions for childhood obesity differ depending on age group, expert says

Community-based interventions designed to prevent obesity in children seem to work best in those under the age of five, while there is evidence of some success in primary school children, but very mixed effects in adolescents, a leading expert in the field said today (Tuesday).

13 Jul 2010

Protalix BioTherapeutics' taliglucerase alfa for Gaucher disease granted French ATU

Protalix BioTherapeutics, Inc. announced today that the French regulatory authority has granted an Autorisation Temporaire d'Utilisation (ATU), or Temporary Authorization for Use, for taliglucerase alfa for the treatment of Gaucher disease. An ATU is the regulatory mechanism used by the French Health Products and Safety Agency to make non-approved drugs available to patients in France when a genuine public health need exists.

13 Jul 2010

SeqWright congratulates EraGen on successful FDA 510(k) market clearance of MultiCode-RTx HSV 1 & 2 Kit

EraGen Biosciences Inc., Madison, Wis., was congratulated today by SeqWright, Inc., Houston, on EraGen's successful FDA 510(k) market clearance of its MultiCode-RTx HSV 1 & 2 Kit. This new kit is the first FDA-cleared PCR-based qualitative in vitro diagnostic test for the detection and typing of HSV-1 and HSV-2 from vaginal lesion swab specimens in symptomatic female patients.

13 Jul 2010

Brains of overweight people are less sensitive to feelings of hunger, finds new research

Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior, the foremost society for research into all aspects of eating and drinking behavior, finds that that feelings of hunger have less influence on how the brain responds to the smell and taste of food in overweight than healthy weight individuals.

13 Jul 2010

Astra Tech expands Atlantis patient-specific abutment options

Astra Tech expands the Atlantis patient-specific abutment options to include Dentsply Friadent's XiVE and Frialit implants and Straumann's Standard/Standard Plus (Wide Neck) implants for North American customers.

13 Jul 2010

Philippine FDA's LSD attains ISO/IEC 17025:2005 accreditation for testing and calibration laboratories

In an effort that will contribute to raising the quality of medicines in the Philippines and surrounding regions, the Laboratory Services Division (LSD) of the Philippine Food and Drug Administration (FDA) has attained the internationally recognized accreditation for testing and calibration laboratories, International Organization for Standardization/ International Electrotechnical Commission (ISO/IEC) 17025:2005.

13 Jul 2010

BioImage Study published in American Heart Journal

BG Medicine, Inc., a U.S.-based biomarker discovery and in vitro diagnostics company, announced today the publication of The BioImage Study trial design and key objectives in the American Heart Journal. The American Heart Journal is a peer- reviewed journal that publishes original research and review articles on clinical research studies in the field of cardiology.

13 Jul 2010

Cepheid denies Abaxis' allegations of patent infringement, files answer and counterclaims

Cepheid announced today that it has filed an answer and counterclaims in a patent suit brought by Abaxis on June 28, 2010 in the United States District Court for the Northern District of California. In its filing, Cepheid denied Abaxis' allegations of patent infringement, asked the Court to determine it has paid all royalties due and is in full compliance with all the terms of its license, and to find that Abaxis' patents are invalid.

13 Jul 2010

MAP Pharmaceuticals reports results from LEVADEX PK and safety clinical trial in smokers, non-smokers

MAP Pharmaceuticals, Inc. today announced results from a clinical trial comparing the pharmacokinetics (PK) and safety of LEVADEX™ orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. The trial was designed to measure whether systemic absorption and exposure in smokers is greater than in non-smokers. In the trial, the systemic absorption of LEVADEX was not higher and systemic exposure to DHE was not greater in smokers than in non-smokers.

13 Jul 2010

RXi Pharmaceuticals receives SBIR grant to further develop novel RNAi therapeutics

RXi Pharmaceuticals Corporation, a recognized leader in RNAi-based therapeutic discovery and development, today announced that it was awarded an Advanced Technology Small Business Innovation Research grant by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

13 Jul 2010

Emergent BioSolutions hosts forum to raise global awareness of the importance of biopreparedness

Emergent BioSolutions Inc. is hosting "Bioterrorism Prevention, Preparedness and Response," a forum organized for members of the North Atlantic Treaty Organization Parliamentary Assembly to raise global awareness of the importance of biopreparedness.

13 Jul 2010

Innocoll submits SPA for phase 3 clinical trial of Cogenzia for adjuvant treatment of infected diabetic foot ulcers

Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Technologies Ltd., has submitted a Special Protocol Assessment (SPA) for a proposed phase 3 clinical trial to support the U.S. approval of Cogenzia™: Innocoll's topical antibiotic therapy for the adjuvant treatment of infected diabetic foot ulcers.

13 Jul 2010

IRIS International, Amerinet announce new supply agreement

IRIS International, Inc. a leading manufacturer of urinalysis systems and consumables for use in hospitals and commercial laboratories worldwide, today announced a new supply agreement for its full product line of automated and semi-automated urinalysis systems, related products, consumables and services agreements, with Amerinet Inc., a leading national healthcare group purchasing organization servicing more than 41,000 provider facilities, including 2,537 acute care hospitals.

13 Jul 2010

Former presidents endorse the Vienna Declaration

Former presidents Fernando Henrique Cardoso (Brazil), Ernesto Zedillo (M-xico) and C-sar Gaviria (Colombia) today announced their endorsement of the Vienna Declaration, the official declaration of the XVIII International AIDS Conference (AIDS 2010, www.aids2010.org) taking place from 18 to 23 July 2010.

13 Jul 2010

Palex to distribute MDI's Detect-Ready MRSA assay in Spain

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Palex Medical S.A., one of Spain's leading distributors of medical device and diagnostic products to hospitals, today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready™ MRSA assay in Spain.

13 Jul 2010

EntreMed announces publication of preclinical data for ENMD-2076

EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.

13 Jul 2010

Deaf, hard of hearing individuals to be provided equal access at N.Y. nursing and rehabilitation facility

Under an agreement announced today by the Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services, individuals who are deaf or hard of hearing will be provided equal access to a nursing and rehabilitation facility in New York State and will be provided interpretation services when necessary for effective communication.

13 Jul 2010

Clinical trial initiated to evaluate LibiGel on cognitive function in menopausal women

BioSante Pharmaceuticals, Inc. today announced the initiation of a LibiGel (testosterone gel) clinical trial to evaluate its effect on cognitive function in menopausal women. The trial is a randomized, 6-month comparison of the effect of LibiGel compared to placebo treatment on a variety of learning and memory tasks. The study is being conducted by Dr. Susan Davis, Professor of Women's Health, Department of Medicine, Monash University Women's Health Program in Australia.

13 Jul 2010

Medical News

Wyse Technology announces partnership, continued success with LLS

Researchers use topological optimization to design facial bone replacements

Community-based interventions for childhood obesity differ depending on age group, expert says

Protalix BioTherapeutics' taliglucerase alfa for Gaucher disease granted French ATU

SeqWright congratulates EraGen on successful FDA 510(k) market clearance of MultiCode-RTx HSV 1 & 2 Kit

Brains of overweight people are less sensitive to feelings of hunger, finds new research

Astra Tech expands Atlantis patient-specific abutment options

Philippine FDA's LSD attains ISO/IEC 17025:2005 accreditation for testing and calibration laboratories

BioImage Study published in American Heart Journal

Cepheid denies Abaxis' allegations of patent infringement, files answer and counterclaims

MAP Pharmaceuticals reports results from LEVADEX PK and safety clinical trial in smokers, non-smokers

RXi Pharmaceuticals receives SBIR grant to further develop novel RNAi therapeutics

Emergent BioSolutions hosts forum to raise global awareness of the importance of biopreparedness

Innocoll submits SPA for phase 3 clinical trial of Cogenzia for adjuvant treatment of infected diabetic foot ulcers

IRIS International, Amerinet announce new supply agreement

Former presidents endorse the Vienna Declaration

Palex to distribute MDI's Detect-Ready MRSA assay in Spain

EntreMed announces publication of preclinical data for ENMD-2076

Deaf, hard of hearing individuals to be provided equal access at N.Y. nursing and rehabilitation facility

Clinical trial initiated to evaluate LibiGel on cognitive function in menopausal women

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

How can super-resolution technology help study neurotransmission?

The Proteoform Puzzle: Unlocking the Next Frontier

Latest News